[go: up one dir, main page]

HN1999000159A - ADMINISTRATION OF ACTIVE AGENT IN DRY POWDER. - Google Patents

ADMINISTRATION OF ACTIVE AGENT IN DRY POWDER.

Info

Publication number
HN1999000159A
HN1999000159A HN1999000159A HN1999000159A HN1999000159A HN 1999000159 A HN1999000159 A HN 1999000159A HN 1999000159 A HN1999000159 A HN 1999000159A HN 1999000159 A HN1999000159 A HN 1999000159A HN 1999000159 A HN1999000159 A HN 1999000159A
Authority
HN
Honduras
Prior art keywords
active agent
dry powder
administration
depths
lung
Prior art date
Application number
HN1999000159A
Other languages
Spanish (es)
Inventor
Inhale Therapeutic Systems Inc
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HN1999000159A publication Critical patent/HN1999000159A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE RELACIONA CON LA ADMINISTRACION MEJORADA DE UNA FORMULACION DE AGENTE ACTIVO EN POLVO SECO HACIA LAS PROFUNDIDADES DEL PULMON.THE PRESENT INVENTION IS RELATED TO THE IMPROVED ADMINISTRATION OF AN ACTIVE AGENT FORMULATION IN DRY POWDER TO THE DEPTHS OF THE LUNG.

HN1999000159A 1998-09-14 1999-09-13 ADMINISTRATION OF ACTIVE AGENT IN DRY POWDER. HN1999000159A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
HN1999000159A true HN1999000159A (en) 1999-11-11

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1999000159A HN1999000159A (en) 1998-09-14 1999-09-13 ADMINISTRATION OF ACTIVE AGENT IN DRY POWDER.

Country Status (44)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
KR (1) KR20010075063A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HK (1) HK1042231A1 (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HUP0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562A0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE20001061A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA99200718B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
UY (1) UY25711A1 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
JP4874483B2 (en) 1999-06-09 2012-02-15 ロバート イー． シーバース Supercritical fluid assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6737042B2 (en) * 2001-05-24 2004-05-18 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
CA2465675C (en) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
BR0307935A (en) 2002-02-25 2005-03-29 Diffusion Pharmaceuticals Llc Bipolar Trans Carotenoid Salts And Their Uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
CA2491129A1 (en) * 2002-07-03 2004-01-15 Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
AU2003298010A1 (en) * 2002-12-19 2004-07-29 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
KR101725225B1 (en) 2004-04-23 2017-04-12 사이덱스 파마슈티칼스, 인크. DPI formulation containing sulfoalkyl ether cyclodextrin
US8030350B2 (en) * 2005-02-24 2011-10-04 Diffusion Pharmaceuticals Llc Trans carotenoids, their synthesis, formulation and uses
RU2007137121A (en) * 2005-03-09 2009-04-20 Оно Фармасьютикал Ко., Лтд. (Jp) PARTICLE AND PREPARATION CONTAINING THE SPECIFIED PARTICLE
PT2952197T (en) 2005-10-26 2017-07-28 Cydex Pharmaceuticals Inc COMPOSITIONS OF CYLODEXTRIN SULFOHYLKYL ETHER AND METHODS FOR THEIR PREPARATION
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20080035143A1 (en) * 2006-08-14 2008-02-14 Sievers Robert E Human-powered dry powder inhaler and dry powder inhaler compositions
WO2008050847A1 (en) * 2006-10-25 2008-05-02 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
EP2146948A4 (en) 2007-04-13 2010-08-04 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
WO2009058399A1 (en) 2007-10-31 2009-05-07 Diffusion Pharmaceuticals Llc A new class of therapeutics that enhance small molecule diffusion
EP2432502B1 (en) * 2009-05-20 2018-01-03 Aeras Stable, spray dried, immunogenic, viral compositions
EP3539542B1 (en) 2009-06-22 2023-04-19 Diffusion Pharmaceuticals LLC Diffusion enhancing compounds and their use with a thrombolytic
CN103124498A (en) 2010-06-02 2013-05-29 扩散药品有限公司 Oral formulations of bipolar trans carotenoids
CN104394846B (en) 2012-05-03 2018-10-19 爱尔兰詹森科学公司 Polyinosinic acid-polycytidylic acid (poly(I:C)) formulations for the treatment of upper respiratory infections
BR112015010601B1 (en) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
US10806770B2 (en) 2014-10-31 2020-10-20 Monash University Powder formulation
JP7032320B2 (en) 2016-03-24 2022-03-08 ディフュージョン・ファーマシューティカルズ・エルエルシー Use of bipolar transcarotenoids with chemotherapy and radiation therapy to treat cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
AU659328B2 (en) * 1992-06-12 1995-05-11 Teijin Limited Ultrafine powder for inhalation and production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
CA2277801C (en) * 1997-01-16 2002-10-15 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
ZA200101995B (en) 2002-03-11
NO20011251D0 (en) 2001-03-13
AP1374A (en) 2005-02-28
ID28845A (en) 2001-07-05
BR9913722A (en) 2001-05-29
BG105430A (en) 2001-12-29
TR200101182T2 (en) 2001-09-21
GT199900156A (en) 2001-03-07
AU6039799A (en) 2000-04-03
EE200100151A (en) 2002-06-17
SK3442001A3 (en) 2001-11-06
IL141562A (en) 2007-07-24
PA8481901A1 (en) 2002-04-25
CN1317977A (en) 2001-10-17
SA99200718B1 (en) 2006-11-04
YU24201A (en) 2003-08-29
TNSN99173A1 (en) 2005-11-10
UY25711A1 (en) 1999-11-17
WO2000015262A1 (en) 2000-03-23
EA003476B1 (en) 2003-06-26
GEP20043257B (en) 2004-06-25
UA76085C2 (en) 2006-07-17
IS5878A (en) 2001-03-05
HUP0103837A2 (en) 2002-05-29
CA2343920A1 (en) 2000-03-23
OA11781A (en) 2005-07-26
NO20011251L (en) 2001-04-17
AR022090A1 (en) 2002-09-04
PL195574B1 (en) 2007-10-31
EP1117442A1 (en) 2001-07-25
IL141562A0 (en) 2002-03-10
LT2001021A (en) 2001-11-26
KR20010075063A (en) 2001-08-09
CO5130023A1 (en) 2002-02-27
DZ2892A1 (en) 2003-12-15
LV12658A (en) 2001-05-20
MA25590A1 (en) 2002-12-31
CZ2001829A3 (en) 2001-09-12
HUP0103837A3 (en) 2002-11-28
LT4897B (en) 2002-02-25
TWI226248B (en) 2005-01-11
AU753014B2 (en) 2002-10-03
HK1042231A1 (en) 2002-08-09
JP2002524535A (en) 2002-08-06
MY129282A (en) 2007-03-30
AP2001002093A0 (en) 2001-03-31
LV12658B (en) 2001-09-20
PE20001061A1 (en) 2000-10-08
EA200100300A1 (en) 2001-10-22
NZ510168A (en) 2003-09-26
PL346768A1 (en) 2002-02-25
HRP20010189A2 (en) 2005-04-30

Similar Documents

Publication Publication Date Title
HN1999000159A (en) ADMINISTRATION OF ACTIVE AGENT IN DRY POWDER.
DK1582204T3 (en) Echinocandin pharmaceutical formulations containing micelle forming surfactants
ES2171971T3 (en) CLEANING AND TREATMENT PRODUCT WITH ALMIDON.
AR024874A1 (en) BACTERICIDE COMPOSITIONS
ES2154503T3 (en) COSMETIC OR DERMATOLOGICAL COMPOSITION.
BG101306A (en) SURFACTORY COMPOSITIONS
DE602005024601D1 (en) TWO COMPONENT DENTAL BLEACHING COMPOSITIONS
MY115628A (en) Cosmetic composition
ES2187749T3 (en) AGROCHEMICAL COMPOSITION PACKAGED.
AR020760A1 (en) DEVICE FOR CONTROLLING THE ADMINISTRATION OF AN ACTIVE AGENT IN AEROSOL IN THE LUNGS OF A HUMAN PATIENT
MX9304742A (en) IMPROVEMENTS IN SOLVENT NON-FLAMMABLE CLEANER WITH SOFT ODOR.
ES2183186T3 (en) COSMETIC COMPOSITIONS IN POWDER CONTAINING SILICONE ELASTOMEROS.
ATE385760T1 (en) REMINERALIZING DENTAL ADHESIVE FILM
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
DE69921318D1 (en) SURFACTANT FOR OUTSIDE SKIN PREPARATIONS AND THESE CONTAINING SKIN PREPARATIONS FOR EXTERNAL USE
EA200200151A1 (en) DRY POWDER COMPOSITION
ATE321534T1 (en) IMPROVED LIPOSOMAL FORMULATION
ES2084105T3 (en) CONDITIONING AGENT FOR FABRICS IN DRYERS, CONTAINING COMPATIBLE SILICONES.
ATE301986T1 (en) COSMETIC STICK PREPARATION
AR027504A1 (en) COMPOSITIONS TO DECOLORATE AND HAVE HAIR
BR9910024A (en) Anti-cold agent
BR0210224A (en) Dosage forms designed to be swallowed directly and presented as a swallowable tablet or capsule formulation and process for preparing a dosage form
ES8401848A1 (en) Composition for intimate feminine hygiene
JPS567711A (en) Cosmetic
ATE203903T1 (en) DELTA-AMINOLEVULIC ACID CONTAINING MEDICINAL PRODUCT